These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35511310)

  • 1. Healthcare costs of diabetic foot disease in Italy: estimates for event and state costs.
    Seghieri C; Ferrè F; Foresi E; Borghini A
    Eur J Health Econ; 2023 Mar; 24(2):169-177. PubMed ID: 35511310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.
    Toscano CM; Sugita TH; Rosa MQM; Pedrosa HC; Rosa RDS; Bahia LR
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29316689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender Differences in the Risk of Adverse Outcomes After Incident Diabetic Foot Hospitalization: A Population Cohort Study.
    Seghieri G; Policardo L; Gualdani E; Francesconi P
    Curr Diabetes Rev; 2022; 18(6):e270821195904. PubMed ID: 34455962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018.
    Bundó M; Vlacho B; Llussà J; Puig-Treserra R; Mata-Cases M; Cos X; Jude EB; Franch-Nadal J; Mauricio D
    Front Endocrinol (Lausanne); 2022; 13():1024904. PubMed ID: 36353236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Foot Risk Classification at the Time of Type 2 Diabetes Diagnosis and Subsequent Risk of Mortality: A Population-Based Cohort Study.
    Wang Z; Hazlehurst J; Subramanian A; Tahrani AA; Hanif W; Thomas N; Singh P; Wang J; Sainsbury C; Nirantharakumar K; Crowe FL
    Front Endocrinol (Lausanne); 2022; 13():888924. PubMed ID: 35898465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
    Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness of diabetic foot disease amongst patients with type 2 diabetes mellitus attending the chronic outpatients department at a regional hospital in Durban, South Africa.
    Goie TT; Naidoo M
    Afr J Prim Health Care Fam Med; 2016 Nov; 8(1):e1-e8. PubMed ID: 28155315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis.
    Cheng SW; Wang CY; Chen JH; Ko Y
    Medicine (Baltimore); 2018 Aug; 97(31):e11602. PubMed ID: 30075532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritisation of diabetes-related footcare amongst primary care healthcare professionals.
    Mullan L; Wynter K; Driscoll A; Rasmussen B
    J Clin Nurs; 2020 Dec; 29(23-24):4653-4673. PubMed ID: 32956503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Burden of Diabetes-Related Foot Disease in New South Wales, Australia: Evidence from the 45 and Up Study Survey Data Linked with Health Services Data.
    Ahmed MU; Tannous WK; Agho KE; Henshaw F; Turner D; Simmons D
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel.
    Melzer Cohen C; Hallén N; Chodick G; Bourvine L; Waner T; Karasik A
    Value Health Reg Issues; 2020 Sep; 22():83-92. PubMed ID: 32798839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United States.
    Joish VN; Zhou FL; Preblick R; Lin D; Deshpande M; Verma S; Davies MJ; Paranjape S; Pettus J
    J Manag Care Spec Pharm; 2020 Mar; 26(3):311-318. PubMed ID: 32105172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foot-related diabetes complications: care pathways, patient profiles and costs.
    Kurkela O; Nevalainen J; Arffman M; Lahtela J; Forma L
    BMC Health Serv Res; 2022 Apr; 22(1):559. PubMed ID: 35473691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.
    Fattore G; Torbica A; Susi A; Giovanni A; Benelli G; Gozzo M; Toso V
    BMC Neurol; 2012 Nov; 12():137. PubMed ID: 23150894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital treatment costs associated with incident complications in patients with type 2 diabetes-real-world study based on electronic patient information systems.
    Sund R; Peltonen T; Lehtimäki AV; Martikainen J
    BMC Health Serv Res; 2022 Apr; 22(1):469. PubMed ID: 35397604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess costs of type 2 diabetes and their sociodemographic and clinical determinants: a cross-sectional study using data from the German Health Interview and Examination Survey for Adults (DEGS1).
    König H; Rommel A; Baumert J; Schmidt C; König HH; Brettschneider C; Konnopka A
    BMJ Open; 2021 Apr; 11(4):e043944. PubMed ID: 33883150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia is independently associated with diabetic foot disease.
    Cheng Q; Hu J; Yang P; Cao X; Deng X; Yang Q; Liu Z; Yang S; Goswami R; Wang Y; Luo T; Liao K; Li Q
    Sci Rep; 2017 Aug; 7(1):8372. PubMed ID: 28827604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up.
    Chen HY; Kuo S; Su PF; Wu JS; Ou HT
    Diabetes Care; 2020 Aug; 43(8):1732-1740. PubMed ID: 32444454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.